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AntioxidantsAbstract Objective: An attempt has been made to evaluate the mitochondrial protection in acute
and chronic periods after isoproterenol (ISO)-induced myocardial-infarction (MI) in male Wistar
rats.
Materials and methods: Luteolin was supplemented by intra-gastric intubation at a daily dose of
0.3 mg/kg body weight for 30 days. In the acute MI model, luteolin had been administered once
per day to rat groups during 30 days. On 29th and 30th days, the rats of the acute MI control
groups were administered 85 mg/kg body weight, isoproterenol, intra-peritoneally at an interval
of 24 h. In the chronic MI model luteolin was supplemented to the rat group during 30 days. On
the 1st and 2nd days, the rats of the chronic MI control and luteolin treatment groups were admin-
istered ISO by the same way.
Results: The isoproterenol-treated rats both in acute and chronic models showed an increase in the
level of TBARS and a decrease in the activities of mitochondrial antioxidants in MI rats, an
increase in levels of mitochondrial lipid proﬁle except phospholipids and the activities of mitochon-
drial enzymes were decreased in isoproterenol-treated rats. Oral treatments with luteolin in both
acute and chronic models showed a signiﬁcant decrease in the levels of mitochondrial lipid perox-
idation, increase in the mitochondrial antioxidant levels and also decrease in the mitochondrial
enzymes.
Conclusion: Thus the present study revealed that luteolin ameliorates mitochondrial damage in
isoproterenol induced myocardial infarction by maintaining lipid peroxidation metabolism due to
320 M. Murugesan, V. Manjuits free radical scavenging, mitochondrial lipids, antioxidants and mitochondrial enzymes. Histopa-
thological observations were also in correlation with the biochemical parameters.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Cardiovascular Diseases (CVDs) remain the principal cause of
death in both developed and developing countries, accounting
for roughly 20% of all worldwide deaths per year. Due to
changing lifestyles in developing countries, such as India and
particularly urban areas, Myocardial infarction is making an
increasingly important contribution to mortality statistics.1
Myocardial mitochondrial damage is considered to be an
important trigger for the pathogenesis of heart disease and is
particularly susceptible to oxidative stress. Ischemia occurring
during myocardial infarction is a potential cause of increased
free radicals that may damage the cellular membrane and inac-
tivate the enzyme of tricarboxylic acid cycle (TCA) and fatty
acid oxidation.2
Isoproterenol (ISO) is a synthetic catecholamine and beta
adrenergic agonist, which causes severe stress in the myocar-
dium, resulting in an infarct like necrosis of the heart muscle3
ISO-induced myocardial infarction serves as a well standard-
ized model, because the pathophysiological changes following
ISO administration are comparable to those taking place in
human myocardial infarction. It produces myocardial necrosis
which caused cardiac dysfunction and increased lipid peroxi-
dation, along with an increase in the level of myocardial lipids
and altered activities of cardiac enzymes and antioxidants.
Mitochondria are the important sub cellular organelles
for cellular oxidative process and also the main source of
reactive oxygen species in the cell. They are the location
of energy production and electron transport chain and carry
out a vital biochemical process called oxidative phosphoryla-
tion. Mitochondria are the main source of energy, which
sustain cellular metabolism and integrity. The decrease in
oxygen supply during MI impairs energy production by
mitochondria.4
Normal cardiac function depends on adequate delivery of
oxygen and oxidizable substrate to generate sufﬁcient ATP
to meet the energy demand of the organ. This process is
achieved through several metabolic pathways, including tricar-
boxylic acid cycle and oxidative phosphorylation, which di-
rectly participate in the generation of ATP.5 ISO-
administration accompanied by alterations in membrane per-
meability brings about a loss of function and integrity of myo-
cardial membranes.6 Myocardial ischemia results in alterations
of cardiac function and ultrastructure. This leads to disruption
of the mitochondria along with the inactivation of the enzymes
concerned with the energy metabolism of myocardium.7
Flavonoids are compounds that are present in a large num-
ber of vegetables and plants such as tea, herbs, citrus fruits and
red wine. Many of them have been shown to be strong free rad-
ical scavengers and antioxidants.8 Luteolin, 30,40,5,7-tetrahydr-
oxyﬂavone, is an important member of the ﬂavonoid family
and usually found in glycosylated forms in celery, green pepper,
common perilla leaf and seed, chamomile ﬂower, and honey-
suckle ﬂower.9 Luteolin possesses a wide range of pharmaco-
logical effects, including antioxidant,10 anti-neoplastic,11anti-hepatotoxic, anti-allergic, anti-osteoporotic,12 and anti-
diabetic.13
In our previous study, we have found that treatment of rats
with luteolin, protected against ISO-induced myocardial ische-
mic injury.14 Although the protection afforded by luteolin was
signiﬁcant with respect to biomarkers of organ damage, oxida-
tive stress and antioxidant enzyme activities, the results indi-
cated that the protection was never complete. Moreover,
although luteolin protective effects through antioxidant mech-
anisms were clearly shown, it remained to be deciphered
whether ISO-induced myocardial injury was owing to distur-
bances in the mitochondrial energy metabolism and whether
induction of apoptosis in the myocardial tissue was one of
the causative factors of myocardial tissue injury. It also re-
mains to be seen whether treatment of rats with luteolin is
capable of providing protection to the heart through mecha-
nisms other than its antioxidant effects.
Thus, the present study is an attempt to indicate the most
therapeutic beneﬁt of luteolin intake by studying its protective
activity against isoproterenol-induced mitochondrial damage
in rats. Our research attempted to demonstrate the molecular
mechanism of its therapeutic effect by studying the lipid frac-
tions, antioxidant enzymes, and other biochemical markers in
the mitochondrial fractions.
2. Materials and methods
2.1. Chemicals
Luteolin and isoproterenol hydrochloride were purchased
from Sigma Chemical Company, St. Louis, MO, USA. All
other chemicals used were of analytical grade.
2.2. Formulation and administration of luteolin
Luteolin powder was suspended in 0.5% Carboxymethyl Cel-
lulose (CMC) and each animal belonging to three different
groups received 1.0 ml of luteolin suspension at a dose of
0.3 mg/kg body weight everyday respectively by intragastric
intubation.10
2.3. Induction of myocardial infarction
2.3.1. Acute Myocardial Infarction (AMI)
The Acute Myocardial Infarction was induced by the intraperi-
toneal (i.p.) injection of isoproterenol hydrochloride (85 mg/kg
body weight, dissolved in physiological saline) on 29th and
30th days.14
2.3.2. Chronic Myocardial Infarction (CMI)
The Chronic Myocardial Infarction was induced by the intra-
peritoneal (i.p.) injection of isoproterenol hydrochloride
(85 mg/kg body weight, dissolved in physiological saline) on
1st and 2nd days.14
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MaleWistar albino rats aged 6 weeks and weighing about 150 g
were obtained from Sri Venkateshwara Enterprises Bangalore,
India.After oneweek of acclimatization all animalswere housed
six per polypropylene plastic cage coveredwithmetal grids and a
hygenic bed of husk in a speciﬁc-pathogen free animal room un-
der controlled conditions of 12 h light/12 h dark cycle, and pro-
vided with standard food pellets (diet composition, wheat
broken-moisture 9.0%, crude protein, 11.5% crude fat, 1.9%
crude ﬁber 4% ash 0.2%, nitrogen-free extract 73.4%) supplied
byHindustan Lever Ltd.,Mumbai, India) and tap water ad libi-
tum. The study was conducted after obtaining a clearance from
the Institutional Animal Ethics Committee (IAEC) (Reg. No.
P.Col/52/2010/IAEC/VMCP) of Vinayaka Mission College of
Pharmacy, Salem, Tamil Nadu.
2.4.1. Experimental design
The rats in group I received 1.0 ml of 0.5% CMC every day via
intragastric intubation and served as the untreated control.
The rats in group II received luteolin via intragastric intuba-
tion at a daily dose of 0.3 mg/kg body weight for a period of
30 days. Group III rats received isoproterenol (85 mg/kg body
weight) intraperitoneally twice at an interval of 24 h on the
29th and 30th days (Acute Myocardial Infarction). Group
IV rats received isoproterenol (85 mg/kg body weight) intra-
peritoneally twice at an interval of 24 h on the 1st and 2nd
days (Chronic Myocardial Infarction). Group V rats received
luteolin as in group II for 30 days and at the end of the exper-
imental period on 29th and 30th days rats received isoprotere-
nol (85 mg/kg body weight) injections intraperitoneally twice
at an interval of 24 h (Acute Myocardial Infarction + Luteo-
lin). Group VI rats received lutoelin as in group II for 30 days
and received isoproterenol (85 mg/kg body weight) intraperito-
neally twice at an interval of 24 h on the 1st and 2nd days
(Chronic Myocardial Infarction + Luteolin).
At the end of the experimental period, rats were sacriﬁced
by cervical decapitation. The blood was collected and serum
obtained after centrifugation was used for various biochemical
estimations. Hearts were removed, cleared of blood and imme-
diately transferred to ice cold containers containing 0.9% so-
dium chloride. Samples of tissues were homogenized in
appropriate buffer and used for the determination of the fol-
lowing parameters.
2.5. Isolation of heart mitochondria
Heart Mitochondria were isolated by the standard procedure
of Takasawa et al.15 The heart tissues were placed in ice cold
50 mM Tris-hydrochloric acid (pH 7.4) containing 0.25 M su-
crose and homogenized. The homogenate was centrifuged at
700g for 20 min, and then the supernatant obtained was centri-
fuged at 9000g for 15 min. Then, the pellets were washed with
10 mM Tris-hydrochloric acid (pH 7.8) containing 0.25 M su-
crose and ﬁnally resuspended in the same buffer.
2.5.1. Estimation of lipid peroxidation products
The levels of Thiobarbituric Acid Reactive Substances
(TBARS) were estimated by the method of Fraga et al.16
1.0 mL of the heart mitochondria was mixed with 2.0 mL of
TCA-TBA-HCl reagent. The mixture was kept in a boilingwater bath for 15 min, cooled, the tubes were centrifuged at
1000g for 10 min and the color developed in the supernatant
was measured in a spectrophotometer at 535 nm against a re-
agent blank. A series of standard solutions in the concentra-
tion range of 2.5–10 mmoles were treated in a similar manner.
2.5.2. Assay of antioxidant enzymes in heart mitochondrial
fraction
Superoxide Dismutase (SOD) Activity was assayed in the
mitochondrial heart by the method of Kakkar et al.17 To
0.5 mL of the heart mitochondria, 1.0 mL of water was added
followed by the addition of 2.5 mL of ethanol and 1.5 mL of
chloroform (chilled reagents were added). This mixture was
shaken for 90 s at 4 C and then centrifuged. The enzyme
activity in the supernatant was determined as follows. The as-
say mixture contained 1.2 mL of sodium pyrophosphate buf-
fer, 0.1 mL of PMS and 0.3 mL of NBT and appropriately
diluted enzyme preparation in a total volume of 3.0 mL. The
reaction was started by the addition of 0.2 mL of NADH.
After incubation at 30 C for 90 s, the reaction was stopped
by the addition of 1.0 mL of glacial acetic acid. The reaction
mixture was stirred vigorously and shaken with 4.0 mL of n-
butanol. The contents were left aside for 10 min, centrifuged
and the n-butanol layer was separated. The color intensity of
the chromogen in n-butanol layer was measured in a spectro-
photometer at 560 nm.
Catalase was estimated by the method of Beers RF and Sei-
zer.18 0.9 mL of phosphate buffer was mixed with 0.1 mL of
isolated heart mitochondria and 0.4 mL of H2O2. The reaction
was arrested after 15, 30, 45 and 60 s by adding 2.0 mL of
dichromate-acetic acid reagent. The tubes were kept in a boil-
ing water bath for 10 min cooled and the absorbance of the
color developed was read in a spectrophotometer at 620 nm.
Glutathione Peroxidase (GPx) was estimated by the method
ofRotruck et al.,19 0.2 mLofTris buffer (0.4 M, pH7.0), 0.2 mL
of EDTA, 0.1 mL of sodium azide and 0.5 mL of isolated heart
mitochondria were mixed together. To this mixture, 0.2 mL of
GSH followed by 0.1 mL ofH2O2was added. The contents were
mixed well and incubated at 37 C for 10 min along with a con-
trol containing all reagents except the homogenate or erythro-
cyte. After 10 min the reaction was arrested by the addition of
0.5 mL of 10% TCA. The contents were centrifuged and the
supernatant was used for the estimation of glutathione.
Reduced Glutathione (GSH) was estimated by the method
of Ellman.20 To 0.5 mL of heart mitochondria, 2.0 mL of 5%
TCA was added to precipitate the proteins. After centrifuga-
tion, to 1.0 mL of supernatant, 3.0 mL of 0.2 M phosphate
buffer and 0.5 mL of Ellman’s reagent were added. The yellow
color developed was read in a spectrophotometer at 412 nm.
2.6. Extraction of mitochondrial lipids
From the Mitochondrial Fraction, the lipids were extracted by
the method of Folch et al.,21 using chloroform:methanol mix-
ture (2:1 v/v). The tissues were rinsed in ice-cold physiological
saline thoroughly and dried by pressing between the folds of
ﬁlter paper. The samples were homogenized in cold chloro-
form–methanol (2:1 v/v) and the contents were extracted after
24 h. The extraction was repeated for four times. The com-
bined ﬁltrate was washed with 0.7% potassium chloride and
the aqueous layer was discarded. The organic layer was made
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biochemical estimations.
2.6.1. Estimation of mitochondrial lipids
Cholesterol in the mitochondrial lipid fraction was estimated by
the method of Zilversmit.22 0.5 mL of the Mitochondrial Lipid
extract was evaporated to dryness. To this extract/0.2 ml of ser-
um, 5.0 ml of ferric chloride-acetic acid reagent was added.
After mixing well, 3.0 ml of concentrated sulfuric acid was
added and the absorbance was read at 560 nm after 20 min.
The levels of triglycerides in themitochondrial lipid fractionwere
estimated by a reagent kit from Accurex Bio Pvt. Ltd., Mumbai.
Free Fatty Acid (FFA) in the Mitochondrial Lipid Fraction
was estimated by the method of Folholt.23 An aliquot of 0.5 mL
of the lipid extract was evaporated to dryness. To the mitochon-
drial extract/0.2 mL of serum, accurately 1.0 mL of phosphate
buffer, 6.0 mL of extraction solvent and 2.5 mL of copper re-
agent were added. All the tubes were shaken vigorously for
90 s and were kept aside for 15 min. Then, the tubes were centri-
fuged and 3.0 mL of the upper layer was transferred to another
tube containing 0.5 mL of diphenyl carbazide solution and
mixed carefully. The absorbance was read at 550 nm after
15 min. 1.0 mL of phosphate buffer was treated as blank.
Phospholipid content in the Mitochondrial Lipid Fraction
was estimated by the method of Zlatkis.24 An aliquot of
0.5 mL of the mitochondrial lipid extract was pipetted out into
a Kjeldahl ﬂask and evaporated to dryness. To the extract/
0.2 mL of serum, 1.0 mL of 5 N Sulfuric Acid was added
and digested in a digestion rack till the appearance of light
brown color. Two to three drops of concentrated Nitric Acid
was added and the digestion continued till it becomes colorless.
The Kjeldahl ﬂask was cooled and 1.0 mL of distilled water
was added and heated in a boiling water bath for about
5 min. Then, 1.0 mL of 2.5% Ammonium Molybdate and
0.1 mL of 1-amino 4-napthol sulfonic acid were added. The
volume was then made up to 5.0 mL with distilled water and
the absorbance was measured at 660 nm within 10 min.
2.7. Assay of heart mitochondrial enzymes
The activities of Isocitrate Dehydrogenase (ICDH) were esti-
mated by the method of King.25 The incubation mixture con-
tained 0.4 mL of buffer, 0.2 mL of substrate, 0.2 ml of
manganese chloride, 0.2 mL of Nicotinamide Adenine Dinu-
cleotide Phosphate and required amount of enzyme source
(mitochondrial fraction). The Nicotinamide Adenine Dinucle-
otide Phosphate was replaced by 0.2 mL of saline in tubes la-
beled as control. A suitable aliquot of enzyme preparation was
added and mixed well. The tubes were then incubated at 37 C
for an hour. At the end of the incubation period, 1.0 mL of the
coloring reagent was added, followed by 0.5 ml of Ethylene
Diamine Tetra Acetic Acid. The contents of the tubes were
mixed well and allowed to stand at room temperature for
20 min and 10 mL of 0.4 N Sodium Hydroxide was added
and the color intensity was measured at 420 nm after 10 min
in a UV-Spectrophotometer.
Succinate Dehydrogenase (SDH) was estimated by the
method of Slater and Bonner.26 The reaction mixture con-
tained 1.0 mL of phosphate buffer, 0.1 mL of Ethylene Dia-
mine Tetra Acetic Acid, 0.1 ml of Sodium Cyanide, 0.1 mL
of Bovine Serum Albumin, 0.3 mL of Sodium Succinate and0.2 mL of Potassium Ferricyanide. The ﬁnal volume of the
mixture was made up to 2.8 mL with distilled water. The reac-
tion was initiated by the addition of 0.2 mL of mitochondrial
fraction. The changes in optical density were recorded at an
interval of 15 s for 5 min at 420 nm.
Malate Dehydrogenase (MDH) was estimated by the meth-
od of Mehler et al.,27 The reaction mixture contained the fol-
lowing reagents and enzyme in a total volume of 3.0 mL.
75 M phosphate buffer, 0.15 M Nicotinamide Adenine Dinu-
cleotide (reduced), 0.76 M Oxaloacetate and 0.2 mL of Mito-
chondrial Fraction. The reaction was carried out at 25 C
and was started by the addition of enzyme preparation. The
control tubes contained all the reagents except Nicotinamide
Adenine Dinucleotide (reduced). The change in optical density
at 340 nm was measured for 2 min at an interval of 15 s in a
UV-Spectrophotometer.
a-Ketoglutarate Dehydrogenase (a-KGDH), was estimated
according to the standard procedure of Reed and Mukherjee.28
The incubation mixture contained 0.15 mL of Phosphate Buf-
fer, 0.1 mL of Thiamine Pyrophosphate, 0.1 mL of Magnesium
sulfate, 0.1 mL of Potassium a-Ketoglutarate, 0.1 mL of
Potassium Ferricyanide and double distilled water to a ﬁnal
volume of 1.4 mL. A suitable aliquot of the enzyme prepara-
tion (Mitochondrial Fraction) was added to tubes labeled as
test and a tube containing double distilled water was labeled
as control. The mixture was then incubated at 30 C for
30 min. At the end of this period, the reaction was terminated
by the addition of 1 ml of 10% Trichloro Acetic Acid. After
the addition of Trichloro Acetic Acid, the enzyme preparation
was added to the control tubes. The samples were centrifuged.
To 1.0 mL of Supernatant, 1.0 mL of 10% Trichloro Acetic
Acid, 1.5 mL of Double Distilled Water, 1.0 of 4% Duponol
and 0.5 mL of Ferric Ammonium sulfate-Duponol Reagent
were added. It was then allowed to stand at room temperature
for 30 min. The color intensity was measured at 540 nm.
2.8. Histopathological examination
After the experimental period, animals were decapitated, and
their livers were removed immediately, then sliced, and washed
in saline. For Histopathological Analysis, Liver Specimens
ﬁxed in 10% formalin were embedded in parafﬁn, sliced at
5-mm thickness, and stained with Hematoxylin and Eosin
for detection of hepatic damage. The pathological changes
were assessed and photographed.
2.9. Statistical analysis
The results presented here are the means ± SD of six rats in
each group. The results were analyzed using one-way analysis
of variance [ANOVA] and the group means were compared
using Duncan’s Multiple Range Test [DMRT] using SPSS ver-
sion 12 for Windows. The ﬁndings were considered as statisti-
cally signiﬁcant if P< 0.05.29
3. Results
3.1. Effect of luteolin on histopathological changes
Normal architecture of the cardiac cells was observed with no evi-
dence of microscopic changes in the control and luteolin treated
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rats the heart shows focal conﬂuent necrosis of the muscle ﬁber
with inﬂammatory cell inﬁltration, edema with ﬁbroblastic prolif-
eration and phagocytosis. In luteolin (0.3 mg/kg body weight) and
isoproterenol (85 mg/kgbodyweight) treated rats, amild degree of
necrosis and less inﬁltration of inﬂammatory cells were seen.
3.2. Effect of luteolin on mitochondrial lipid peroxidation and
antioxidant levels in the myocardial infarction rats
Table 1 depicts the effect of luteolin on levels of mitochondrial
TBARS in the control and experimental rats. The levels were
signiﬁcantly (P< 0.05) increased in the acute and chronic
periods of ISO alone-induced rats (groups 3 and 4) as com-
pared with normal control rats (group 1). Pre and Post Luteo-
lin administration to Acute & Chronic Isoproterenol treated
rats (groups 5 and 6) signiﬁcantly (P< 0.05) decreased the lev-
els of mitochondrial TBARS as compared with acute and
chronic periods of ISO alone-induced rats (groups 3 and 4).
Rats induced with Isoproterenol showed a signiﬁcant
(P< 0.05) decrease in the activities of Peroxidase EnzymesFigure 1 Histopathology changes in the myocardial infarction of co
induced myocardial infarction in rats. (A) Normal control heart showin
twice with a duration of 24 h) control heart showing focal conﬂuent nec
ﬁbroblastic proliferation and phagocytosis along with extravasation of
duration of 24 h) control heart showing cardiac muscle ﬁbers with mu
splitting of muscle bundles. (D) Group IV (Luteolin) heart showed no
of necrosis and less inﬁltration of inﬂammatory cells; F). Group VI (
alone with inﬁltration of a small amount of inﬂammatory cells, necro(SOD, CAT) and other endogenous antioxidant enzymes
(GPx, GSH) in the heart mitochondria, when compared to nor-
mal control rats (group 1). Oral treatment with luteolin (0.3 mg/
kg) to Isoproterenol-induced rats daily for a period of 28 days
signiﬁcantly (P< 0.05) increased the activity of SOD and
CAT in the heart mitochondria, when compared with isoprote-
renol-induced untreated rats of both acute and chronic periods.
The activities of endogenous antioxidant enzymes were signiﬁ-
cantly increased in the heart mitochondria and the levels of
GPx and GSH also increased signiﬁcantly in the heart mito-
chondria of isoproterenol-induced rats (Table 1) of both acute
and chronic periods when compared with acute and chronic
periods of ISO alone-induced rats (groups 3 and 4).
3.3. Effect of luteolin on heart mitochondrial lipids in the
myocardial infarction rats
Table 2 depicts the levels of mitochondrial cholesterol, FFA
and triglycerides in isoproterenol-induced rats which were sig-
niﬁcantly (P< 0.05) increased and the level of phospholipids
in the heart mitochondria signiﬁcantly (P< 0.05) decreasedntrol and experimental rats. Effect of Luteolin on Isoproterenol
g normal cardiac muscle ﬁbers. (B) Group II (AMI) ISO (85 mg/kg
rosis of muscle ﬁber with inﬂammatory cell inﬁltration, edema with
red blood cells. (C) Group III (CMI) ISO (85 mg/kg twice with a
scle separation and inﬂammatory collections, cardiac necrosis and
changes. E) Group V (AMI + Luteolin) rats showing mild degree
CMI + Luteolin) showing some cardiac muscle cell denaturation
sis was not obvious.
Table 1 Effect of luteolin on heart mitochondrial thiobarbutric acid reactive substances (TBARS) and antioxidants in the control and
experimental rats.
Groups Control Luteolin
(0.3 mg/kg b.wt)
AMI
Isoproterenol
(85 mg/kg b.wt)
CMI Isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ AMI-isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ CMI-isoproterenol
(85 mg/kg b.wt)
TBARS
(nmoles/mg
protein
6.28 ± 0.56a 6.11 ± 0.39a 10.73 ± 0.63b 11.8 ± 0.16b 8.52 ± 0.16c 8.11 ± 0.16d
Superoxide
dismutase
(SOD)
(units/mg
protein)
20.2 ± 0.58a 21.11 ± 0.52a 14.73 ± 0.54a 13.8 ± 0.16a 17.5 ± 0.16c 16.8 ± 0.16c
Catalase
(CAT)
(nmoles of H2O2
consumed/min/
mg protein)
2.52 ± 0.15a 2.46 ± 0.15a 0.86 ± 0.35b 0.62 ± 0.27b 1.58 ± 0.32d 1.65 ± 0.32b
Glutathione
peroxidase
(GPx)
(nmoles of GSH
oxidized/min/
mg protein)
1.37 ± 0.14a 1.32 ± 0.24a 0.91 ± 0.19a 0.85 ± 0.19a 1.03 ± 0.26b 1.15 ± 0.26b,c
Reduced
Glutathione
(nmoles GSH
reduced /mg
protein)
7.45 ± 0.24a 7.52 ± 0.34a 4.41 ± 0.29c 4.25 ± 0.19c 5.63 ± 0.26b,c 5.49 ± 0.26a,b
The results are expressed as mean ± SD of six rats in each group. Values not sharing a common superscript (a, b, c, d) differ signiﬁcantly with
each other P< 0.05.
Table 2 Effect of luteolin on the levels of heart mitochondrial lipids in the control and experimental rats.
Groups Control Luteolin
(0.3 mg/kg b.wt)
AMI
Isoproterenol
(85 mg/kg b.wt)
CMI Isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ AMI-isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ CMI-isoproterenol
(85 mg/kg b.wt)
Triglyceride
(nmoles/mg protein)
18.61 ± 1.54a 12.91 ± 1.25a 24.60 ± 1.39b 26.81 ± 1.29b 21.75 ± 1.42b 22.21 ± 1.89a,c
Cholesterol
(nmoles/mg protein)
36.61 ± 2.84a 34.01 ± 1.55a 56.60 ± 4.39b 58.81 ± 3.91b 42.75 ± 3.42b 44.21 ± 3.39c
Free fatty acids
(nmoles/mg protein)
15.67 ± 0.83a 14.52 ± 0.63a 27.29 ± 3.25b 29.11 ± 2.62c 18.46 ± 0.86d 17.75 ± 1.47b
Phospholipids
(nmoles/mg protein)
580.93 ± 37.58a 584.10 ± 36.15a 463.22 ± 24.23b 458.44 ± 23.38c 526.10 ± 26.11b 528.41 ± 26.22b,d
The results are expressed as mean ± SD of six rats in each group. Values not sharing a common superscript (a, b, c, d) differ signiﬁcantly with
each other P< 0.05.
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and 4) as compared to the control rats (group 1). Treatment
with Luteolin (0.3 mg/kg) daily for a period of 30 days signif-
icantly (P< 0.05) decreased the levels of cholesterol, FFA, tri-
glycerides and signiﬁcantly (P< 0.05) increased the levels of
phospholipids in the heart Mitochondrial Fractions of Isopro-
terenol-induced rats when compared with Isoproterenol-in-
duced untreated rats (Table 2).3.4. Effect of luteolin on the activities of mitochondrial enzymes
in the control and experimental rats
The activities of Tricarboxylic Acid (TCA) cycle enzymes were
measured to analyze the role of Luteolin on energy metabolism
(Table 3). The activities of ICDH, SDH, MDH and a-KGDH
were decreased signiﬁcantly (P< 0.05) in the acute and
chronic periods of ISO-induced rats (groups 3 and 4) as
Table 3 Effect of luteolin on the activities of mitochondrial enzymes in the control and experimental rats.
Groups Control Luteolin
(0.3 mg/kg b.wt)
AMI Isoproterenol
(85 mg/kg b.wt)
CMI Isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ AMI-isoproterenol
(85 mg/kg b.wt)
Luteolin
(0.3 mg/kg b.wt)
+ CMI-isoproterenol
(85 mg/kg b.wt)
Isocitrate
dehydrogenase
(ICDH)
764.6 ± 72.15a 754.6 ± 71.35a 537.2 ± 56.16b 532.6 ± 55.18b 657.33 ± 57.16c 663.38 ± 58.17c
Succinate
dehydrogenase
(SDH)
41.15 ± 1.16a 42.12 ± 1.26a 16.77 ± 0.22b 15.23 ± 0.29c 35.45 ± 0.91b,c 35.66 ± 0.21d
Malate
dehydrogenase
(MDH)
337.21 ± 0.95a 339.16 ± 0.85a 158.16 ± 1.35b 157.92 ± 1.27c 255.15 ± 1.32d 256.95 ± 1.11b,c
a-ketoglutarate
dehydrogenase
(a-KGDH)
80.17 ± 0.5a 95.32 ± 0.84a 65.1 ± 1.19d 63.5 ± 0.92b 77.3 ± 1.26c 78.9 ± 1.31b,c
ICDH units: n moles of a-ketoglutarate formed/h/mg protein; SDH: nmol of succinate oxidized/min/mg protein; MDH units: nmoles of NADH
oxidized/min/mg protein; a-KGDH units: nmoles of ferrocyanide formed/h/mg protein.
The results are expressed as mean ± SD of six rats in each group. Values not sharing a common superscript (a, b, c, d) differ signiﬁcantly with
each other P< 0.05.
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the deleterious effect of Isoproterenol on TCA cycle enzymes.
Treatment with Luteolin(0.3 mg/kg) daily for a period of
30 days signiﬁcantly (P< 0.05) increased the activities of these
enzymes in Isoproterenol-induced rats, when compared to Iso-
proterenol-induced untreated rats (Table 3).4. Discussion
The current knowledge about the beneﬁcial effects of Nutra-
ceuticals represents a great impact on nutritional therapy
and stimulated the research on favorable properties of bioac-
tive compounds enriched Nutraceuticals.30
Mitochondria play a central role in the energy-generating
process within the cell. Apart from this important function,
mitochondria are involved in complex process such as apopto-
sis. The Cardioprotective actions of potassium channel openers
have revealed that cardiac mitochondria are more important as
the primary targets of these drugs than the plasma membrane.
Mitochondrial Membrane contains relatively large amount
of polyunsaturated fatty acids in its phospholipids which are
highly susceptible to Lipid Peroxidation, an important deteri-
oration in biological membrane.31 Lipid Peroxidation, a type
of oxidative deterioration of polyunsaturated fatty acids, has
been linked with altered membrane structure and enzyme inac-
tivation. Elevated levels of Lipid Peroxidation (TBARS) in
heart mitochondrial fraction may decrease mitochondrial
membrane ﬂuidity, increase negative surface charge distribu-
tion and alter membrane ionic permeability including proton
permeability, which uncouples oxidative Phosphorylation.32
Thus, accelerated Lipid Peroxidation damages both the struc-
ture and the function of the heart mitochondria in ISO-treated
rats. Oral treatment with Luteolin signiﬁcantly decreased the
concentration of TBARS in the Isoproterenol-induced rats.
The former is known to increase antioxidant activity in Lipid
Peroxidation and protect cells from oxidative damage.33 Our
results conﬁrmed the anti-lipid peroxidative action of Luteolinagainst Isoproterenol-induced mitochondrial damage in myo-
cardium. Thus, Luteolin protected the heart from myocardial
damage by scavenging free radicals and thereby blocking the
Peroxidation of Lipids in mitochondria.
When ROS generation exceeds the antioxidant capacity of
cells, oxidative stress develops, potentially causing tissue dam-
age. The oxidative stress may be exerted through Quinone
metabolites of ISO that react with oxygen to produce superox-
ide anions and other ROS and interfere with antioxidant en-
zymes. In the present study, Isoproterenol administration
was found to reduce the levels of GSH and antioxidant en-
zymes in the cardiac mitochondria such as SOD, CAT and
GPx, and this observation concurs with the earlier ﬁnding.34
Decreased activities of these enzymes by ROS may affect the
heart mitochondria substrate oxidation, resulting in reduced
oxidation of substrates, reduced rate of transfer of reducing
equivalents to molecular oxygen, and depletion of cellular en-
ergy. Mitochondrial and cellular damage can be prevented by
increasing intracellular GSH content.
Treatment with Luteolin signiﬁcantly increased the levels of
SOD and CAT in the mitochondrial fraction of Isoproterenol-
induced rats. Luteolin may act as an antioxidant by scavenging
ROS and also improving the endogenous antioxidant system
in Isoproterenol-induced rats.35 The activities of GSH-depen-
dent enzymes and the level of GSH in ISO-treated rats that
might be due to their free radical scavenging and antioxidant
properties. Thus, increased levels of GSH prevented mitochon-
drial damage in Luteolin pretreated ISO-induced rats.
In our study, altered levels of lipids were observed in the
Mitochondrial Fraction of the heart. The increased levels of
Mitochondrial Lipids indicate clear evidence for altered car-
diac function and ultrastructure in MI. Activation of the Lipid
Peroxidation process resulted in changes in lipid composition.
Increased levels of Mitochondrial Cholesterol are well associ-
ated with MI.36 We observed an increased level of cholesterol
in the mitochondria of heart tissue in Isoproterenol-induced
rats which suggests redistribution of cholesterol in the Mito-
chondria of Ischemic Cells. Increased cholesterol levels in the
326 M. Murugesan, V. Manjumitochondrial membrane affect the permeability of ions and
the ﬂuidity. The metabolic products of Isoproterenol produced
more free radicals and the Phospholipid rich mitochondrial
membrane is vulnerable to free radical attack. This may be
the reason for decreased levels of phospholipids in mitochon-
drial fractions of the heart of Isoproterenol-induced rats. This
may be due to the increased activity of Phospholipase A2 by
Ca2+, which is an inducer of Phospholipase A2. Treatment
with Luteolin signiﬁcantly increased the level of phospholipids
in the Isoproterenol-induced rats. Luteolin ability to counter
free radical attack may protect phospholipids in mitochondria.
In addition, we observed an increased level of triglycerides
and free fatty acids in the Isoproterenol-induced rats. Previous
reports37,38 suggested that the decreased delivery of fatty acids
from the Cardiomyocytes reverses triglyceride accumulation
and leads to contractile dysfunction, and it may also be due
to a decrease in the activity of lipoprotein lipase, resulting in
the decreased uptake of TGs from the circulation.39 Mitochon-
dria utilize FFAs as energy fuel by oxidative metabolism and
remaining FFAs are used as precursors for the synthesis of
fat and Triacylglycerol. When the supply of oxygen is reduced
as in MI, oxidation of FFAs ceases, leading to increased syn-
thesis of Triacylglycerol due to FFA accumulation.40 In-
creased levels of FFAs inhibit respiratory activities and
depress cardiac function in ischemic condition.41 Alteration
in myocardial metabolism resulted in increased levels of TGs
in the mitochondrial fraction of ISO-treated rats.
Treatment with Luteolin reduced the levels of triglycerides
and free fatty acids in Isoproterenol-induced rats. Luteolin
may channel fatty acids to Triacylglycerol synthesis and divert
lipids from toxic metabolic pathways. The accumulation of
free fatty acids is a consequence of changes in myocardial lipid
metabolism. Thus, in the ischemic heart, hydrolysis of phos-
pholipids prevails in myocardial mitochondria. These changes
in the metabolism of the sub cellular fraction may lead to dam-
age of the membranes of the Cardiac Myocyte Mitochondria,
which may be the cause of disorders of electrolyte metabolism
and contractile properties of the myocardium.
The Mitochondrial Enzymes (ICDH, SDH, MDH and a-
KGDH) catalyze the oxidation of several substrates through
the Tricarboxylic Acid (TCA) cycle, yielding reducing equiva-
lents, which are channeled through the respiratory chain for
the synthesis of ATP by oxidative Phosphorylation. Inhibition
of these enzymes by Reactive Oxygen Species (ROS) may af-
fect the mitochondrial substrate oxidation, resulting in reduced
oxidation of substrate, reduced rate of transfer of reducing
equivalents to molecular oxygen and depletion of cellular en-
ergy.42 Thus the marker enzymes of TCA cycle are affected
by the free radicals produced by ISO.
Isocitratre Dehydrogenase is mainly expressed in the heart
and skeletal muscle mitochondria. It is NADP dependent and
controls the mitochondrial redox balance and the subsequent
oxidative damage.43 The high activity of ICDH can contribute
to the regeneration of reduced glutathione in heart mitochon-
dria, resulting in amarkedly high resistance of the heart enzymes
against oxidative stress. SDH is one of the important enzymes
that regulate the production of ATP inmitochondria. It is a typ-
ical thiol (SH) group enzyme and sensitive to free radicals.
Isoproterenol administration to rats signiﬁcantly decreased
the activities of TCA cycle enzymes, such as ICDH, SDH,
MDH and a-KGDH. During myocardial infarction, pro-
nounced enhancement of Lipid Peroxidation was seen inthe Mitochondria. These Dehydrogenases are located in the
outer membrane of the mitochondria and are affected by in-
creased levels of free radicals produced following isoprotere-
nol administration.44 These enzymes are located in the
mitochondrial membrane and could have been affected by
the excessive production of free radicals induced by ISO.
Inhibition of these enzymes by ROS may affect the mitochon-
drial substrate oxidation, resulting in reduced oxidation of
substrates, reduced rate of transfer of reducing equivalents
of molecular oxygen and depletion of cellular energy.45 Treat-
ment with Luteolin showed signiﬁcantly improved activities
of TCA cycle enzymes in the heart mitochondrial fraction
in ISO-treated rats due to their free radical scavenging
activities.
Histopathological ﬁndings also support the ﬁndings of this
study. The ISO-induced myocardium showed focal conﬂuent
necrosis of muscle ﬁber with inﬂammatory cell inﬁltration,
edema with ﬁbroblastic proliferation and phagocytosis. Nor-
mal control rats treated with Luteolin (0.3 mg/kg body weight)
showed normal cardiac ﬁbers without any pathological
changes. This indicates that Luteolin (0.3 mg/kg body weight)
does not possess any adverse effects under normal condition.5. Conclusion
We conclude that Luteolin exhibits a protective role in Isopro-
terenol induced myocardial infarction in rats by preserving the
integrity of mitochondrial membranes from Lipid Peroxida-
tion, and restoring the activities of antioxidants and mitochon-
drial enzymes to near normal levels and histopathological
analysis suggests its Cardioprotective action. This could be
due to the antioxidant effect of Luteolin. A diet containing
Luteolin could prove beneﬁcial to the heart.Acknowledgements
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